Tokyo Tape
Sign in
← Sakai Chemical Industry

Quarterly report · Q2

4078.TEDINET S100PH2A
Period2022-04-01 → 2022-09-30
Filed2022-11-09
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥42.7bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥80.1bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥39.9bn2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥3.3bn2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥4.4bn2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥3.8bn2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥8.8bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥4.6bn2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥4.2bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥4.5bn2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥2.9bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥6.7bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥3.2bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥3.0bn2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥3.3bn2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥128.4bnat 2022-09-30Cons.Assets
Total assets¥123.9bnat 2022-03-31Cons.Assets
Total assets¥124.5bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥42.6bnat 2022-09-30Cons.Liabilities
Total liabilities¥41.2bnat 2022-03-31Cons.Liabilities
Net assets / equity¥85.8bnat 2022-09-30Cons.Net assets
Net assets / equity¥82.7bnat 2022-03-31Cons.Net assets
Net assets / equity¥82.3bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥11.9bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥10.8bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥11.7bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥10.5bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥11.8bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥11.2bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥1.1bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥6.6bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥5.4bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥1.3bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.7bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥3.8bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow¥1.0bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥5.7bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥1.0bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥177.482022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥68.082022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥407.062021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥188.852021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥91.632021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio63.6%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio63.6%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio63.2%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥860m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥860m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥1.1bn
jpcrp040300-q2r_E00780-000Chemicalreportable segmentrevenue2022-04-01 → 2022-09-30¥39.3bn
jpcrp040300-q2r_E00780-000Chemicalreportable segmentrevenue external2022-04-01 → 2022-09-30¥38.6bn
jpcrp040300-q2r_E00780-000Chemicalreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥697m
jpcrp040300-q2r_E00780-000Chemicalreportable segmentsegment profit2022-04-01 → 2022-09-30¥4.2bn
jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segmentrevenue2022-04-01 → 2022-09-30¥4.3bn
jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segmentrevenue external2022-04-01 → 2022-09-30¥4.1bn
jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥163m
jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segmentsegment profit2022-04-01 → 2022-09-30¥240m
—segment totalrevenue2022-04-01 → 2022-09-30¥43.6bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥42.7bn
—segment totalrevenue intersegment2022-04-01 → 2022-09-30¥860m
—segment totalsegment profit2022-04-01 → 2022-09-30¥4.4bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-09-30−¥684m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-09-30−¥684m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥977m
jpcrp040300-q2r_E00780-000Chemicalreportable segmentrevenue2021-04-01 → 2021-09-30¥36.4bn
jpcrp040300-q2r_E00780-000Chemicalreportable segmentrevenue external2021-04-01 → 2021-09-30¥35.8bn
jpcrp040300-q2r_E00780-000Chemicalreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥548m
jpcrp040300-q2r_E00780-000Chemicalreportable segmentsegment profit2021-04-01 → 2021-09-30¥5.1bn
jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segmentrevenue2021-04-01 → 2021-09-30¥4.2bn
jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segmentrevenue external2021-04-01 → 2021-09-30¥4.1bn
jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥136m
jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segmentsegment profit2021-04-01 → 2021-09-30¥233m
—segment totalrevenue2021-04-01 → 2021-09-30¥40.6bn
—segment totalrevenue external2021-04-01 → 2021-09-30¥39.9bn
—segment totalrevenue intersegment2021-04-01 → 2021-09-30¥684m
—segment totalsegment profit2021-04-01 → 2021-09-30¥5.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 510
ItemContextValueUnit
Proceeds from insurance income ope cfPrior1YTDDuration－JPY
Proceeds from insurance income ope cfCurrentYTDDuration521000000JPY
Income taxes paid ope cfPrior1YTDDuration-757000000JPY
Income taxes paid ope cfCurrentYTDDuration-1795000000JPY
Net cash provided by used in operating activitiesPrior1YTDDuration5383000000JPY
Net cash provided by used in operating activitiesCurrentYTDDuration1122000000JPY
Purchase of property plant and equipment inv cfPrior1YTDDuration-3837000000JPY
Purchase of property plant and equipment inv cfCurrentYTDDuration-1319000000JPY
Proceeds from sales of property plant and equipment inv cfPrior1YTDDuration27000000JPY
Proceeds from sales of property plant and equipment inv cfCurrentYTDDuration1000000JPY
Purchase of investment securities inv cfPrior1YTDDuration-15000000JPY
Purchase of investment securities inv cfCurrentYTDDuration-33000000JPY
Proceeds from sales of investment securities inv cfPrior1YTDDuration128000000JPY
Proceeds from sales of investment securities inv cfCurrentYTDDuration181000000JPY
Other net inv cfPrior1YTDDuration-121000000JPY
Other net inv cfCurrentYTDDuration-115000000JPY
Net cash provided by used in investment activitiesPrior1YTDDuration-3818000000JPY
Net cash provided by used in investment activitiesCurrentYTDDuration-1285000000JPY
Net increase decrease in short term loans payable fin cfPrior1YTDDuration24000000JPY
Net increase decrease in short term loans payable fin cfCurrentYTDDuration2569000000JPY
Proceeds from long term loans payable fin cfPrior1YTDDuration300000000JPY
Proceeds from long term loans payable fin cfCurrentYTDDuration－JPY
Repayment of long term loans payable fin cfPrior1YTDDuration-1311000000JPY
Repayment of long term loans payable fin cfCurrentYTDDuration-949000000JPY
Purchase of treasury stock fin cfPrior1YTDDuration-0JPY
Purchase of treasury stock fin cfCurrentYTDDuration-0JPY
Cash dividends paid fin cfPrior1YTDDuration-1000000JPY
Cash dividends paid fin cfCurrentYTDDuration-565000000JPY
Dividends paid to non controlling interests fin cfPrior1YTDDuration-36000000JPY
Dividends paid to non controlling interests fin cfCurrentYTDDuration-48000000JPY
Payments from changes in ownership interests in subsidiaries that do not result in change in scope of consolidation fin cfPrior1YTDDuration-0JPY
Payments from changes in ownership interests in subsidiaries that do not result in change in scope of consolidation fin cfCurrentYTDDuration-0JPY
Net cash provided by used in financing activitiesPrior1YTDDuration-1025000000JPY
Net cash provided by used in financing activitiesCurrentYTDDuration1006000000JPY
Effect of exchange rate change on cash and cash equivalentsPrior1YTDDuration81000000JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYTDDuration274000000JPY
Net increase decrease in cash and cash equivalentsPrior1YTDDuration621000000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration1118000000JPY
Cash and cash equivalentsPrior2YearInstant11153000000JPY
Cash and cash equivalentsPrior1YearInstant10549000000JPY
Cash and cash equivalentsPrior1QuarterInstant11774000000JPY
Cash and cash equivalentsCurrentQuarterInstant11667000000JPY
Discounted trade notes receivablePrior1YearInstant0JPY
Discounted trade notes receivableCurrentQuarterInstant1000000JPY
Haulage expenses sgaPrior1YTDDuration1052000000JPY
Haulage expenses sgaCurrentYTDDuration1073000000JPY
Employees salaries and allowances sgaPrior1YTDDuration1854000000JPY
Employees salaries and allowances sgaCurrentYTDDuration1904000000JPY
Provision for bonuses sgaPrior1YTDDuration587000000JPY
Provision for bonuses sgaCurrentYTDDuration653000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass